Publications by authors named "Miku Wada"

Claim this Profile
T
The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells.
Asako Kukita, Kenbun Sone, Syuzo Kaneko, Eiryo Kawakami, Shinya Oki, Miku Wada, Osamu Wada-Hiraike

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
Miku Wada, Asako Kukita, Kenbun Sone, Ryuji Hamamoto, Syuzo Kaneko, Osamu Wada-Hiraike

Biomolecules· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.
Asako Kukita, Kenbun Sone, Katsutoshi Oda, Ryuji Hamamoto, Syuzo Kaneko, Miku Wada, Osamu Wada-Hiraike

Biochem Biophys Res Commun· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis